Are you Dr. Hoofnagle?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 26 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1 Center Dr
Op9 Acrf
Bethesda, MD 20892Phone+1 301-496-6000Fax+1 301-480-8300- Is this information wrong?
Summary
- Dr. Jay Hoofnagle, MD is a gastroenterologist in Bethesda, Maryland. He is currently licensed to practice medicine in Maryland.
Education & Training
MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1975 - 1977
University of Virginia Medical CenterResidency, Internal Medicine, 1971 - 1972
Yale School of MedicineClass of 1970
Certifications & Licensure
MD State Medical License 1976 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Publications & Presentations
PubMed
- Non-Hispanic Black persons with nonalcoholic fatty liver disease have lower rates of advanced fibrosis, cirrhosis, and liver-related events even after controlling for ...Niharika Samala, Yuchen Xin, Laura A Wilson, Katherine Yates, Rohit Loomba, Jay H Hoofnagle, Naga Chalasani> ;The American Journal of Gastroenterology. 2024 Mar 14
- Letter to the Editor: A multi-society Delphi consensus statement on new fatty liver disease nomenclature.Jay H Hoofnagle, Edward Doo> ;Hepatology. 2024 Mar 1
- Symptoms of Liver Disease During Tenofovir Therapy With or Without Peginterferon: Results from the Hepatitis B Research Network Immune Active Trial.Donna M Evon, Hsing-Hua S Lin, Mandana Khalili, Abdus S Wahed, Colina Yim, Robert J Fontana, Jay H Hoofnagle> ;Digestive Diseases and Sciences. 2023 Dec 1
- Join now to see all
Press Mentions
Your NEJM Group Today: Hepatitis C & Nobel Prize / Shorter Tx for Diabetic Foot Osteomyelitis? / Onc-Hem & Hepatology OpportunitiesDecember 10th, 2020- Hepatocellular Carcinoma Recurrence and Death Following Living and Deceased Donor Liver TransplantationJuly 23rd, 2020
- Use of Corticosteroids After Hepatoportoenterostomy for Bile Drainage in Infants with Biliary Atresia: The START Randomized Clinical TrialMay 7th, 2020
- Join now to see all
